Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BAT IT: Banked Anti-SARS Cov-2 T Cell Infusions for Treatment of COVID 19

NCT04401410 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT04401410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04401410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BAT IT: Banked Anti-SARS Cov-2 T Cell Infusions for Treatment of COVID 19
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
November 4, 2020
Completion date
October 12, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19, sars-cov 2, viral infection